Skip to content

INFINITY™ EVERLAST™ 33684309Recalls & reported problems

Wright Medical Technology, Inc. · Class 2 · Implant

All models of INFINITY EVERLAST (20)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
5
Deaths reported
0
Injuries reported
5
Recalls naming it
0

Summary

The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 00889797074568), received between Jul 19, 2022 and Nov 13, 2025 — classified as 5 injuries.

The most frequently reported specific device problem is “Migration” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 1 reportsNov 2025: 1 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem3
  • Migration2
  • Insufficient Device Problem Information1

Patient problems

  • Swelling/ Edema2
  • Bone Fracture(s)1
  • Erythema1
  • Insufficient Information1
  • Joint Impingement1
  • Pain1
  • Post Operative Wound Infection1
  • Unspecified Infection1

Recent adverse event reports

The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.

  • InjuryNov 13, 2025Insufficient Device Problem Information; Insufficient Device Problem Information

    THE DIGITAL STRYKER PROPHECY TEAM RECEIVED A CT SCAN INDICATING THAT THE PATIENT MAY REQUIRE A REVISION SURGERY FOR REASONS UNKNOWN

    Patient problems: Insufficient Information

    MAUDE report 23550239 ↗
  • InjuryOct 28, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    SUBJECT: (B)(6). INFINITY WITH ADAPTIS ANKLE (ITAR-2) STUDY. L MEDIAL ANKLE IMPINGEMENT. PERSISTENT PAIN. NARRATIVE OF ADVERSE EVENT: CONTINUED PAIN MEDIAL ANKLE AFTER TAA. PERFORMED DEBRIDEMENT (B)(6) 2022.

    Patient problems: Joint Impingement; Pain

    MAUDE report 23402220 ↗
  • InjuryOct 3, 2023Migration; Migration

    CLINICAL STUDY INFINITY¿ WITH ADAPTIS¿ TECHNOLOGY TOTAL ANKLE REPLACEMENT FOLLOW-UP (ITAR2): SUBJECT (B)(6). AS REPORTED: "FACTURE LINES UNDER TALUS PROSTHESIS WITH LOSS OF TALAR HEIGHT. DURING 6 MONTH FOLLOW UP VISIT (B)(6) 2023, EVIDENCE OF TALUS SUBSIDENCE WAS DOCUMENTED IN RADIOGRAPHIC FOLLOW-UP AND CT WAS REQUESTED. THE CT OF THE LEFT ANKLE PERFORMED ON (B)(6) 2023 WAS REVIEWED WITH PATIENT ON (B)(6) 2023 WITH FINDINGS OF FRACTURE LINES UNDER THE TALUS PROSTHESIS WITH LOSS OF TALAR HEIGHT. PHYSICAL EXAMINATION SHOWED MILD LEFT ANKLE TENDERNESS TO PALPITATION AND MODERATE SWELLING. SURGICAL INTERVENTION WAS RECOMMENDED DUE TO FAILED CONSERVATIVE MEASURES. PATIENT WILL REQUIRE REVISION TOTAL ANKLE REPLACEMENT WITH CUSTOM TALAR COMPONENT DUE TO TALUS FRACTURE LOSS OF HEIGHT. "

    Patient problems: Bone Fracture(s); Swelling/ Edema

    MAUDE report 17861147 ↗
  • InjuryMay 25, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    THERE WAS A REPORTED WOUND DEVELOPMENT AND SUBSEQUENT INFECTION AT SURGICAL INCISION SITE OF LEFT ANKLE. ANTIBIOTIC COURSES INCLUDING BACTRIM, DOXYCYCLINE, AND LEVAQUIN AS WELL AS WOUND CARE INCLUDING TOPICAL SILVADENE WERE TRIALED. SURGICAL INTERVENTION FOR WOUND DEBRIDEMENT, IRRIGATION, VANCOMYCIN POWDER APPLICATION, AND PLACEMENT OF PICO WOUND VAC DRESSING WERE PERFORMED.

    Patient problems: Post Operative Wound Infection

    MAUDE report 17002858 ↗
  • InjuryJul 19, 2022Adverse Event Without Identified Device or Use Problem; Migration; Adverse Event Without Identified Device or Use Problem; Migration

    IT WAS REPORTED THAT THE PATIENT UNDERWENT A TOTAL ANKLE REPLACEMENT. ALLEGEDLY, THE PATIENT CAME INTO SURGEONS OFFICE WITH SWELLING AND REDNESS. THE SURGEON ATTEMPTED TO TREAT BY ASPIRATING THE ANKLE AND TREATED WITH ANTIBIOTICS. INFECTION PERSISTED, SO THE SURGEON REMOVED THE PROSTHESIS AND REPLACED IT WITH AN ANTIBIOTIC SPACER. DUE TO INFECTION AND TIBIAL LOOSENING, PATIENT REQUIRED EXPLANTATION OF PROSTHESIS, IMPLANTATION OF ANTIBIOTIC CEMENT SPACER, AND WILL REQUIRE A REVISION.

    Patient problems: Erythema; Swelling/ Edema; Unspecified Infection

    MAUDE report 15059745 ↗

Other PROSTHESIS, ANKLE, SEMI-CONSTRAINED, CEMENTED, METAL/POLYMER devices

All PROSTHESIS, ANKLE, SEMI-CONSTRAINED, CEMENTED, METAL/POLYMER devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page